Close

Cantor Fitzgerald Upgrades Ventrus Biosciences (VTUS) to Buy as Oct. Catalysts Loom

August 10, 2012 1:59 PM EDT Send to a Friend
Cantor Fitzgerald upgraded Ventrus Biosciences (NASDAQ: VTUS) from Hold to Buy with a price target of $7.00 (from $5.50).

This article: 170 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login